Page last updated: 2024-09-03

glycyl-arginyl-glycyl-aspartyl-seryl-proline and Carcinoma, Ductal, Breast

glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Carcinoma, Ductal, Breast in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aleporou-Marinou, V; Drosos, Y; Georgoulis, A; Goutas, N; Havaki, S; Kittas, C; Kouloukoussa, M; Marinos, E; Vlachodimitropoulos, D1

Other Studies

1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Carcinoma, Ductal, Breast

ArticleYear
RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.
    Ultrastructural pathology, 2012, Volume: 36, Issue:6

    Topics: Actins; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Adhesion; Cell Movement; Cell Shape; Female; Humans; Integrin alphaVbeta3; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microscopy, Immunoelectron; Oligopeptides; Primary Cell Culture; Protein Binding; Tissue Culture Techniques; Tumor Cells, Cultured

2012